Gene-editing Xenograft Model

Advanced Xenograft Services for Precision Oncology Research

Gene-editing Xenograft Model Overview

Kyinno Bio develops custom xenograft tumor models with precise genetic modifications, allowing researchers to:
✔ Knock out, knock in, or overexpress specific genes to investigate tumor progression.
✔ Replicate patient-derived mutations for personalized medicine studies.
✔ Evaluate the efficacy of targeted therapies in relevant cancer models.
✔ Predict patient responses to novel anti-cancer treatments.

gene editing xenograft using mice

Gene-edited xenograft tumor models, such as CRISPR/Cas9, are employed to modify the genome of tumor cells by knocking out, overexpressing, or knocking in genes to simulate the occurrence and development of human cancer and to study specific targets. These models are valuable for investigating the mechanisms of cancer development, testing the efficacy of new drugs, and predicting patient responses to anti-cancer treatments. KYINNO has established thousands of gene-edited cell models, encompassing both human tumor cells and mouse-derived tumor cells, providing a powerful tool for scientific research.

Gene-Editing Xenograft Model Workflow

Our gene-editing xenograft services follow a structured approach, ensuring precision and reproducibility in preclinical cancer research:

1️⃣ Genome Editing & Cell Line Development – Using CRISPR/Cas9 to modify human or mouse-derived tumor cells.
2️⃣ Tumor Model Establishment – Engrafting gene-edited cells into immunodeficient or syngeneic mouse models.
3️⃣ Therapeutic Testing & Drug Screening – Evaluating drug responses in vivo.
4️⃣ Tumor Growth Monitoring & Imaging – Using bioluminescence, fluorescence, or PET imaging for real-time tracking.
5️⃣ Comprehensive Data Analysis – Assessing oncogene activity, resistance pathways, and drug efficacy.

Our gene-editing xenograft models are designed for highly targeted preclinical investigations, ensuring reliable and translatable results.

Advantages of Our Xenograft Services

Kyinno Bio’s gene-editing xenograft models provide a flexible and reliable platform for studying genetic drivers of cancer. Key advantages include:

✔ Customizable CRISPR/Cas9 Gene Editing – Enabling precise genetic modifications.
✔ Diverse Tumor Models – Covering solid tumors, hematological malignancies, and rare cancers.
✔ Human & Mouse-Derived Cell Lines – Supporting cross-species genetic research.
✔ Integrated Drug Screening Capabilities – Testing novel kinase inhibitors, immunotherapies, and chemotherapies.
✔ Validated in Preclinical & Translational Research – Providing highly predictive in vivo data.

Using state-of-the-art gene-editing technologies, our xenograft services support high-throughput oncology research and targeted drug development.

Expert Support for Xenograft Model Development

Our team provides comprehensive support throughout gene-edited xenograft development:

  • Custom Model Design & Consultation – Developing xenografts tailored to research needs.
  • Genomic Validation & Quality Control – Ensuring accurate gene modifications.
  • Real-Time Tumor Monitoring – Supporting bioluminescence, PET, and MRI imaging.
  • Regulatory Guidance for IND Applications – Assisting in preclinical data generation.

Our expertise in gene editing, xenograft model development, and oncology research, we help researchers generate high-quality, translatable preclinical data.

How to Get Started with Kyinno Bio

Enhance your preclinical oncology research with Kyinno Bio’s xenograft services. Our custom gene-editing xenograft models support oncogene research, targeted therapy validation, and immuno-oncology drug testing.

We provide customized in vivo study designs, ensuring high-quality, data-driven insights for drug development. Contact us today to explore how our xenograft services can support your research.

Frequently Asked Questions (FAQs) About Xenograft Services

All In Vivo Services

Ba/F3 Xenograft focuses on protein kinases, a cornerstone in cancer research. With FDA’s acknowledgment of kinase drugs, it offers important oncology insights aiding for deeper understanding.
Gene-edited xenografts utilizes tools like CRISPR/Cas9, and offer precise modifications to tumor cell genomes. This significantly expands the horizons and potential of modern oncological research methodologies and insights.
The Luciferase tumor model provides insights into tumor growth and immune dynamics. Using bioluminescence, it provides real-time insights. This innovative approach deepens comprehension, advancing cancer research and promoting novel therapeutic discoveries.
PBMC Humanized Mouse Model incorporates human T cells’ behavior, enabling detailed tumor immunology analysis. It presents a unique avenue for in-depth exploration, enriching research and offering a comprehensive study platform.
The Syngeneic Model leverages the uses of mouse-derived tumor tissues, placed into genetically similar hosts, contributing to consistency and depth in cancer studies. Ensures a genuine environment for cancer study.
The Orthotopic tumor models are a leading choice for evaluating anti-cancer drug efficacy, supporting clinical trials, and understanding potential treatments. Its established method is a key component in therapeutic research.
The subcutaneous tumor model is one of the most commonly used in vivo evaluation systems for assessing the efficacy of novel anti-cancer drugs. Typically, tumor  …
In cancer research, metastasis models are critical tools that help us understand how tumors migrate from their original location to other parts of the body. Ba/F3 cells are a common type of tumor cell, especially in mouse models, where they exhibit metastasis.